Sinisa Franjic graduated from the Faculty of Law. Thesis entitled "Legal aspects of information systems" he was defended Summa Cum Laude and become an LLM of Law. Since 1992., he work as a journalist - freelance contributor to the first Radio Osijek of HRT (Croatian Radio Television), and then something shorter, among other media, he worked for HTV - TV center Osijek, weekly "Skolske novine (School Newspaper)“ and the monthly "Super Kino Video (Super Cinema video)". In the academic year 2009./2010., Faculty of Electrical Engineering in Osijek (today Faculty of Electrical Engineering, Computer Science and Information Technology Osijek) appointed him as a part-time assistant on the course "Computer Criminality". With Computer Criminality, he studying Medical Law and a few other legal disciplines. In the Faculty of Electrical Engineering in Osijek he participated in the teaching of the courses "Computer Criminality" and "Legal Regulations in Electrical Engineering and Computer Science" and in the Faculty of Medicine in Osijek, he participated in the teaching of the courses "Social and Health Legislation" and "Medicine and Health Law". The successful defense of his doctoral dissertation on the topic of Criminal law called "The Criminal Justice and Forensic Aspects of Computer Criminality", he received a Ph.D. in the area of Criminal law and Criminalistics/Forensics. He is the author of several books and many scientific papers. He actively participates in scientific journals as a reviewer and Editorial Board member and member of Organizing Committees an international scientific conferences.

Education: Faculty of Pharmacy, Medical University, Lublin, Poland; Master’s degree (highest honor); Doctoral thesis in pharmacology (highest honor), Department of Pharmacodynamics; Habilitation thesis in Pharmacology (highest honor), idem; since 2010–Full Professor degree, now: the Head of the Chair and Department of Pharmacology and Pharmacodynamics; 2012-2021 – Vice-Dean, 2021-2024– Dean of the Faculty of Pharmacy, Medical University of Lublin, Poland. Author of 417 papers, if=325 and a patent; tutor of 15 doctoral thesis, citation index=32. Member of numerous scientific societies, incl. the Committee of Physiological and Pharmacological Sciences of the Polish Academy of Sciences, member of the Editorial boards of 25 foreign journals, incl. Neurochemical Research and Molecules; award-winning, incl. three times with the awards of the Minister of Health and the Jędrzej Śniadecki price of the Polish Academy of Science (in 2019), Golden Medal for Long Service, Honorary Medal of Merit for Healthcare, Bronze and Silver Cross of Merit, Medal of the Medical University of Lublin, place on the TOP 2% list in the ranking World's TOP 2% Scientists containing the names of researchers whose publications are the most cited organized by Stanford University, USA in (three times; 2021-2023). Principle investigator of projects financed from external sources (i.e., NCN Opus) and EU projects, incl. High Quality Medical Education (2019-2023), NAWA Polonium (international polish-french grant, twice, now: 2024-25) and an international grant from the Visegrad Founds (2022-23). In the years 1991-2010, numerous (7 in total) research fellowships in France (INSERM grants and the Ministry of Higher Education and Research (MESR) and 11 stays at European universities under the Erasmus + program. National and foreign expert of many organizations. Invited lectures and in plenary sessions, also in French and English. Languages: Polish: native; French: fluently; English, Russian. Research subjects: psychopharmacology, pharmacotherapy, experimental pharmacology. Significant scientific, didactic and organizational experience in experimental pharmacology, neuropsychopharmacology, pharmacotherapy and neurobiology, especially in the context of research on the central nervous system and neuropsychiatric disorders. Scientific works focused on behavioral studies of the role of various neurotransmitter systems in the action of addictive substances. The main topics include: central effects of psychoactive compounds and natural products, anxiety, stress, memory and learning, depression, nociception, Parkinson's and Alzheimer's disease, dementia, psychosis, rewarding drug effects, measured in behavioral paradigms, with mice, rats and zebrafish (Danio rerio); molecular mechanisms common to addiction and memory processes (e.g., the effects of the endocannabinoid and cholinergic systems, calcium homeostasis and kinase/phosphatase balance, chronic stress) and neuropsychiatric disorders and further pharmacotherapy strategies; pharmacological screening of newly synthesized compounds and natural products isolated from plants.

Prof. Yehuda Shoenfeld is the founder and head of the Zabludowicz Center for Autoimmune Diseases, at the Sheba Medical Center, which is affiliated to the Sackler Faculty of Medicine in Tel-Aviv University in Israel. Professor Shoenfeld’s clinical and scientific works focus on autoimmune and rheumatic diseases, and he has published more than 1750 papers in journals such as New Eng J Med, Nature, The Lancet, Proc Nat Acad Scie, J Clin Invest, J Immunol, Blood, FASEB, J Exp Med, Circulation, Cancer and others. Professor Shoenfeld is on the editorial boards of 43 journals in the fields of rheumatology and autoimmunity and is the founder and the editor of the IMAJ (Israel Medical Association Journal), the representative journal of science and medicine in the English language in Israel, and also is the founder and Editor of Autoimmunity Reviews (Elsevier) (Impact factor 7.9) and co-Editor of the Journal of Autoimmunity (Impact factor 8). For the past twenty years Yehuda has been the Editor of “Harefuah” – The Israel Journal in Medicine (Hebrew). Professor Shoenfeld received the EULAR prize in 2005, in Vienna, Austria. In UC Davis, USA, Professor Shoenfeld received the Nelson’s Prize for Humanity and Science for 2008. He was recently awarded a Life Contribution Prize in Internal Medicine in Israel, 2012 as well as the ACR Master Award in 2013.

Professor Luiz Moutinho (BA, MA, PhD, MAE, FCIM) is a Fellow and Visiting Professor of Marketing at Suffolk Business School, Faculty of Arts, Business and Applied Social Science, University of Suffolk, Ipswich, England, UK, and at The Marketing School, Portugal and Adjunct Professor of Marketing, Graduate School of Business, Faculty of Business and Economics, University of the South Pacific, Suva, Fiji. In 2020 he was elected as the member of The Academia Europaea. In 2017 he received a degree of Prof. Honoris Causa from the Univ. of Tourism and Management Skopje, North Macedonia. During 2015 - 2017 he was professor of BioMarketing and Futures Research at the DCU Business School, Dublin City University, Ireland. This was the first Chair in the world on both domains - BioMarketing and Futures Research. Previously, and for 20 years, he had been appointed as the Foundation Chair of Marketing at the Adam Smith Business School, University of Glasgow, Scotland. Previously, he got his first Chair in 1989 at the University of Wales College of Cardiff 1989-2006. Professor Moutinho completed his PhD at the University of Sheffield in 1982. He has been a Full Professor for 34 years and has held Visiting Professorship positions at numerous universities worldwide. He is the Founding Editor-in-Chief of the Journal of Modelling in Management (JM2) and Co-editor-in-Chief of the Innovative Marketing Journal. His main areas of research interest encompass marketing, management and tourism futurecast, artificial intelligence, biometrics and neuroscience theory, evolutionary algorithms, human-computer interaction, the use of artificial neural networks in marketing, modelling processes of consumer behaviour, futures research. Prof. Moutinho has given keynote speeches, lectures, seminars, talks, etc. in 46 countries worldwide. Prof. Moutinho has 38 books published, over 159 articles published in refereed academic journals. He has 16250 academic citations, the h-index of 59 and the i10-index of 160 (Google Scholar, August 12th, 2023).

Dr. Pedro A. Jose is Professor of Medicine, University of Maryland School of Medicine, Adjunct Professor of Biochemistry and Molecular & Cellular Biology, Georgetown University School of Medicine and Visiting Professor, Third Military Medical University of the People’s Republic of China, Chongqing, P.R. China and Anhui Institute of Cardiovascular Disease, Anhui Provincial Hospital, Anhui, P.R. China. He has been invited as a guest lecturer in several universities in Australia, China, France, Germany, Ireland, Japan, Portugal, Sweden, Philippines, and USA and plenary speaker in several international meetings of learned societies. Dr. Jose received his MD degree, magna cum laude, meritissimus, from the University of Santo Tomas, Philippines, and placed first in the Philippine National Board Examinations in Medicine and Surgery. He received his PhD degree in Physiology from Georgetown University, Washington, DC and defended his dissertation with distinction. He is certified by the American Board of Pediatrics, American Sub-Board of Pediatric Nephrology, and American Society of Hypertension. He was President of the American Society of Pediatric Nephrology. Dr. Jose has chaired and continues to chair Study Sections and Emphasis Panels of the US National Institutes of Health and voluntary organizations, such as the American Heart Association and National Kidney Foundation. He reviews grant applications in foreign countries, including Italy and the Czech Republic. Dr. Jose has extensive experience in basic and translational research. The primary goal of Dr. Jose’s research is to determine the genetic bases of human essential hypertension. He has published over 340 scientific articles in prestigious journals and books including Circulation Research, Hypertension, Journal of the American Society of Nephrology, Journal of Clinical Investigation, Nature Genetics, and Proceedings of the National Academy of Sciences. His publications are cited more than 7,800 times with 41 cited more than 50 times, 17 of which are cited more than 100 times; four are covers of scientific journals and six are the subject of editorial commentaries. Dr. Jose has received several academic awards, including the 2003 Lewis K. Dahl Memorial Lecture (Council for High Blood Pressure Research, American Heart Association), 2007 Ernest H. Starling Distinguished Lecture (American Physiological Society Water and Electrolyte Homeostasis Section) and a 2007 MERIT award from the National Institutes of Health. He is a fellow of the Council for High Blood Pressure Research, American Heart Association. A key finding of Dr. Jose’s research is the demonstration of the crucial role of variants of a gene “G protein-coupled receptor kinase type 4 or GRK4” in the pathogenesis of high blood pressure in humans. Dr. Jose also showed that variations of GRK4 are very important in predisposing an individual to develop salt-sensitive high blood pressure. These studies have resulted in a patent in the US (# 6,660,474) and Japan (#4652566), patent-pending in Europe and Australia) and a provisional patent on “Compositions and Methods for Identifying and Diagnosing Salt Sensitivity of Blood Pressure” (US Provisional Patent Application #61,636,576).Variants of GRK4 may also predict the response to anti-hypertensive drugs, an example of pharmacogenomics. Four of his National Institutes of Health research grant applications received perfect scores of 10 (Project 3 of 5P01HL074940 [2009], Project 4 of 5P01HL068686 [2012], HL092196 [2013], and R01DK039308 [2011]). Dr. Jose’s research is currently funded by three R01 grants in which he is the principal investigator, two P01 grants in which he is the director of program projects, and one grant from pharma. Deciphering the role of GRK4 gene variants, in the pathogenesis of human essential hypertension, was the second advance and discovery cited by the Director of NHLBI for its FY 2004 Budget Justification to the US Congress.

Lianshu Ding M.D., Ph.D.  Director, Professor, consultant doctor Dept of Neurosurgery, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University  Engaged in neurosurgery for over 30 years, mainly focusing on treatment and research on brain tumors and neurotrauma  Visited and studied neuro-oncology in Neurological Institute, Department of Neurosurgery of Cleveland Clinic in 2010 Education 2007—2010 Post Doctorate of Science in Neurosurgery, Nanjing Medical University 2002—2005 Doctor of Science in Neurosurgery, Southern Medical University 1997—2000 M.S. in Neurosurgery, Nantong University 1984—1989 B. S. in Neurosurgery, Xuzhou Medical College

Neil Bindemann, Exec Director, Person-Centred Neurosciences Society In the past 10 years I have integrated and applied my BSc Immunology and Neurosciences PhD to an experience arising from a brain tumour diagnosis. It has been through of that whole living experience that I have been drawn to create a more person-centred emotional health services with the aim of empowering people to rebalance their immune system. This led to evolving the Primary-Care Neurology Society (originally founded in 2005) into the first ever Person-Centred society that focuses on lifestyle neuroscience - still known by many as the P-CNS. Then, in 2022, coming out of a period working with the British Society of Lifestyle Medicine I co-founded the Lifestyle Health Foundation.

David Wortley is the author of “Gadgets to God”, a historical perspective of mankind’s changing relationship with technology over the last 60 years and a vision of the future impact of disruptive communications technologies on business and society. He is also a freelance consultant on the strategic use of immersive and emerging technologies such as serious games, virtual worlds and social networks. His passion is helping organisations and individuals to leverage the power of these technologies for competitive advantage and business/personal development. He is a Fellow of the Royal Society of Arts (FRSA) with a career which has embraced the converging and emerging technologies of telecommunications (Post Office Telecommunications), computing (IBM), digital media and community informatics (Mass Mitec, a rural SME) and the creative industries (De Montfort University Leicester, UK). He is a serial entrepreneur and innovator with a passion for applying technology to social and economic development. David recently supported De Montfort University in Leicester as a Research Fellow in the Art, Design and Humanities Faculty. He was also Founding Director of the Serious Games Institute (SGI) www.seriousgamesinstitute.co.uk at Coventry University and was responsible for the development of the Institute as a global thought leader on the application of immersive technologies (which include video games; virtual worlds and social networking) to serious social and economic issues such as education; simulation; health; commerce and climate change. Working with academics; regional development agencies and leading computer games companies, David made the SGI a focal point for games based learning, simulation and immersive 3D virtual environments and an engine for innovation and social and economic regeneration. David is a respected and sought-after international conference speaker and writer for global publications on Learning Technologies, Defence and Health applications. He has written numerous papers on technology and society and is a regular conference presenter.

Professor Luiz Moutinho (BA, MA, PhD, MAE, FCIM) is a Fellow and Visiting Professor of Marketing at Suffolk Business School, Faculty of Arts, Business and Applied Social Science, University of Suffolk, Ipswich, England, UK, and at The Marketing School, Portugal and Adjunct Professor of Marketing, Graduate School of Business, Faculty of Business and Economics, University of the South Pacific, Suva, Fiji. In 2020 he was elected as the member of The Academia Europaea. In 2017 he received a degree of Prof. Honoris Causa from the Univ. of Tourism and Management Skopje, North Macedonia. During 2015 - 2017 he was professor of BioMarketing and Futures Research at the DCU Business School, Dublin City University, Ireland. This was the first Chair in the world on both domains - BioMarketing and Futures Research. Previously, and for 20 years, he had been appointed as the Foundation Chair of Marketing at the Adam Smith Business School, University of Glasgow, Scotland. Previously, he got his first Chair in 1989 at the University of Wales College of Cardiff 1989-2006. Professor Moutinho completed his PhD at the University of Sheffield in 1982. He has been a Full Professor for 34 years and has held Visiting Professorship positions at numerous universities worldwide. He is the Founding Editor-in-Chief of the Journal of Modelling in Management (JM2) and Co-editor-in-Chief of the Innovative Marketing Journal. His main areas of research interest encompass marketing, management and tourism futurecast, artificial intelligence, biometrics and neuroscience theory, evolutionary algorithms, human-computer interaction, the use of artificial neural networks in marketing, modelling processes of consumer behaviour, futures research. Prof. Moutinho has given keynote speeches, lectures, seminars, talks, etc. in 46 countries worldwide. Prof. Moutinho has 38 books published, over 159 articles published in refereed academic journals. He has 16250 academic citations, the h-index of 59 and the i10-index of 160 (Google Scholar, August 12th, 2023).

Albin Kaelin, CEO epeaswitzerland gmbh, Author Albin Kaelin is the founder, owner and CEO of epeaswitzerland gmbh since its foundation in 2009 and has driven the development and implementation of the Cradle to Cradle® design concept in various areas of the company. As early as 1993, he initiated the development of the Climatex® product line, which produced the world's first Cradle to Cradle® products. Cradle to Cradle® design creates recyclable products by setting itself apart from conventional recycling and maintaining the quality of the raw materials over several product life cycles. All materials are considered nutrients and are used in defined cycles at the right time and in the right place. Awards: Honored with over 30 awards since 2022, including IE 100 Award- 2024 and 2025 Albin Kaelin - Most Innovative CEO of The Year testify to his leadership and innovative spirit.

Dr. Manfred Doepp Born in Bad Berleburg/Germany. Medical studies in Munich and Giessen, exams and doctorate in 1971. Scientific assistant at the clinical centre of the Justus Liebig University at Giessen until 1978. Senior physician for nuclear medicine at the clinical centre in Hanau until 1985. Founder of the "International Institute for Experiential Medicine, Founder of the "Diagnostic Centre for Mineral Analysis and Spectroscopy DCMS. From 2011 to 2018 Head Physician of the Quantisana Health Centre for Holistic Diagnostics and Therapy in CH 9404 Rorschacherberg. Since 2018 Head of the HolisticCenter in CH 9030 Abtwil. Many oral and written publications in the field of complementary and energy medicine. Many videos on Youtube, Google and complementary portals. Reviewer of international journals. Co-founder and Deputy President of DGEIM.

Anwesha Dutta is a dedicated neuroscience researcher with over eight years of experience in clinical and non-clinical studies, specializing in neuropsychiatric disorders. With a strong background in molecular biology, neuroimaging, and data analysis, she has contributed to groundbreaking research on bipolar disorder, psychosis, and Alzheimer's disease. Her work at Newcastle Magnetic Resonance Centre advanced lithium neuroimaging, while her epigenetic studies at King’s College London uncovered novel DNA methylation patterns linked to psychiatric conditions. As an R&D coordinator at AIzheimers UK, she integrates neuroimaging and AI for early dementia detection. Passionate about translational neuroscience, she actively bridges research and innovation to improve diagnostic and therapeutic strategies in neuropsychiatry

I hold a Master’s degree in neuroscience from King’s College London, where I have specialized in molecular neurobiology and neurodegenerative disease research. My work includes CRISPR-Cas9 genome editing, zebrafish behavioral models, RT-PCR, and confocal microscopy, with a focus on conditions such as ALS, Alzheimer’s, and Duchenne muscular dystrophy. I have been part of collaborative research projects across India, the UK, and the US, and I am passionate about advancing translational neuroscience.

Epilepsy is a neurological disorder characterized by recurrent seizures, which can affect individuals’ daily lives significantly. Understanding the public’s knowledge, attitudes, and practices (KAP) towards epilepsy is crucial for effective health education and management strategies. This study aimed to assess the perception, attitude and practice among a rural population in Sudan towards epilepsy. Method and Materials: This study was a descriptive cross-sectional, community-based study conducted in March 2023 at a rural area in Gezira state in the central part of Sudan. A self-constructed questionnaire was designed by authors based on revision of previous similar studies. It consisted of four domains: The first domain was about sociodemographic data (age, gender, occupation, residence and educational level). The second, third and fourth domains consisted of questions regarding knowledge, attitude and practice. 150 participants were involved in this study and data was analysed by SPSS version 22. Results: The total number of participant in this study was 150 individuals. The majority (83) were females (55.3%) and 36% of respondents were in the age group (15-30). The overall net result of KAP of the participants in this study towards epilepsy was as follows: for knowledge it was 67.9%, attitude 63.5% and practice 53.9%. There was no significant association between gender and knowledge of epilepsy, P-value 0.887. Conclusion: The current study’s findings underscore the need for targeted educational interventions to dispel myths and misconceptions about epilepsy. Increasing awareness through community-based programs can help reduce the stigma and improve the quality of life for epileptic individuals. Comparative analysis with other studies highlights the universal challenge of epilepsy-related stigma and the critical role of education in mitigating its impact.

Florent Pirot is a multidisciplinary researcher with Einstein Syndrome and specialties in geophysics, nuclear physics, astrophysics as well as biology and health. He got his graduate in economics and political sciences (Sciences Po Lille, College of Europe and CAPES in economics and sociology).